I cannot belive the ~600kUSD for the bond was/ is
Post# of 147816
I am also not sure if it is that simple to get the data directly from the HIV trial sites. I would assume the trial sites have contracts with the CRO (AMAREX) and not with Cytodyn. So there could also be some legal issues(?) I guess they have no obligation to hand over data directly to Cytodyn.
For HIV, the receptor occupancy test is more concerning for me. Did we get any update/ confirmation that FDA finally accepted our new tests and that we have everything for the BLA in this regard? Did I miss something (again)?
The delay of the bond does not really fit into any picture ...